Perelman School of Medicine

Penn is fighting pancreatic cancer

Researchers within the Penn Pancreatic Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress.

Drug found to trigger the ‘energy balance’ system for appetite suppression

Penn researchers show how the FDA-approved drug liraglutide interacts with a distinct set of neurons in the brain’s “energy balance” system to suppress appetite.

outline of a human head with five contrasting profiles in decreasing size throughout the brain area

Schizophrenic no more: Two subcategories in the brain redefine a blanket diagnosis

In a study of more than 300 patients from three continents, a second type of schizophrenia was discovered by observing brain matter that looks healthy, but with increased volumes of gray matter in the basal ganglia.

A lab worker wearing latex gloves holds a vial of blood in a lab

A new way to predict lung cancer treatment response: The blood test

A Penn study shows a better clinical response to immunotherapy correlates with higher ratio of tumor mutations detected by a liquid biopsy.

Machine learning identifies personalized brain networks in children

A Penn study shows variability among children’s neural anatomy which may inform personalized treatments for psychiatric disorders.

Q&A

Tales of bringing the dead back to life

Meet Vikram Paralkar, an oncologist at Penn Medicine who has received extraordinary attention for his new fiction novel, “Night Theater,” a story where a surgeon is asked to bring the dead back to life.

DNA misfolding in white blood cells increases risk for Type 1 diabetes

A new Penn Medicine study shows that changes in a DNA sequence may cause chromosomes to misfold in a way that elevates the risk for autoimmune diseases.

Managing pain in the age of opioids

Medical professionals from the Perelman School of Medicine, the School of Dental Medicine, and the School of Veterinary Medicine discuss treating pain during the opioid crisis.

A reality check on coronavirus

The novel disease is serious. But risks here remain low, says Ezekiel J. Emanuel, vice provost for global initiatives, who attended a World Health Organization meeting on the subject last week.

microscopic view of the inside of a blood vessel

Vasculitis treatment with fewer steroids

The insights from the PEXIVAS Trial, a 10-year study, shows treatment for ANCA-associated vasculitis can become much more patient-friendly and reduces kidney failure, for which vasculitis patients are often at risk.

Filters